Zobrazeno 1 - 10
of 120
pro vyhledávání: '"F. Ida"'
Autor:
Douglas H. Jones, MD, Priya Bansal, MD, Jonathan A. Bernstein, MD, Shahnaz Fatteh, MD, Joseph Harper, PharmD, F. Ida Hsu, MD, Maeve O’Connor, MD, Nami Park, PharmD, Daniel Suez, MD
Publikováno v:
World Allergy Organization Journal, Vol 15, Iss 1, Pp 100621- (2022)
Background: Hereditary angioedema (HAE) is often caused by low serum levels or functional deficiency in C1 inhibitor (C1-INH); however, in some cases, C1-INH serum level and function are measured as normal (HAE-nl-C1INH). Management of HAE-nl-C1INH i
Externí odkaz:
https://doaj.org/article/532c5bdec9a240c88b9e8106405ecd30
Autor:
Jones, Douglas H., Bansal, Priya, Bernstein, Jonathan A., Fatteh, Shahnaz, Harper, Joseph, Hsu, F. Ida, O’Connor, Maeve, Park, Nami, Suez, Daniel
Publikováno v:
In World Allergy Organization Journal January 2022 15(1)
Autor:
Brooks, Joel P., Radojicic, Cristine, Riedl, Marc A., Newcomer, Scott D., Banerji, Aleena, Hsu, F. Ida
Publikováno v:
In The Journal of Allergy and Clinical Immunology: In Practice June 2020 8(6):1875-1880
Autor:
Romberg, Neil, Le Coz, Carole, Glauzy, Salomé, Schickel, Jean-Nicolas, Trofa, Melissa, Nolan, Brian E., Paessler, Michele, Xu, Mina L., Lambert, Michele P., Lakhani, Saquib A., Khokha, Mustafa K., Jyonouchi, Soma, Heimall, Jennifer, Takach, Patricia, Maglione, Paul J., Catanzaro, Jason, Hsu, F. Ida, Sullivan, Kathleen E., Cunningham-Rundles, Charlotte, Meffre, Eric
Publikováno v:
In The Journal of Allergy and Clinical Immunology January 2019 143(1):258-265
Autor:
Tobias M. Suiter, Radana Zachova, Sladjana Andrejevic, Anna Valerieva, Ralph Shapiro, Katarina Hrubiskova, Ljerka Karadza-Lapic, Roman Hakl, Vesna Grivcheva-Panovska, Maria Staevska, D. Soteres, Vinay Mehta, Milos Jesenak, Marta Sobotkova, F. Ida Hsu, Jeffrey Rumbyrt, Andrea Zanichelli, Raffi Tachdjian
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 8:799-802
Hereditary angioedema (HAE), an inherited deficiency offunctional C1 esterase inhibitor (C1-INH), is characterized byrecurrent episodes of disabling and often painful swelling insubcutaneous and/or submucosal tissues.1HAE attacks aregenerally unpredi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ec0619934bfec4ec2bba07735f3efe8
https://doi.org/10.1016/j.jaip.2019.08.011
https://doi.org/10.1016/j.jaip.2019.08.011
Autor:
Valerieva, Anna, Staevska, Maria, Jesenak, Milos, Hrubiskova, Katarina, Sobotkova, Marta, Zachova, Radana, Hakl, Roman, Andrejevic, Sladjana, Suiter, Tobias, Grivcheva-Panovska, Vesna, Karadza-Lapic, Ljerka, Soteres, Daniel, Shapiro, Ralph, Rumbyrt, Jeffrey, Tachdjian, Raffi, Mehta, Vinay, Hsu, F. Ida, Zanichelli, Andrea
Publikováno v:
In The Journal of Allergy and Clinical Immunology: In Practice February 2020 8(2):799-802
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Joel P Brooks, Marc A. Riedl, Cristine Radojicic, Scott D. Newcomer, F. Ida Hsu, Aleena Banerji
Publikováno v:
The journal of allergy and clinical immunology. In practice. 8(6)
Consensus guidelines recommend plasma-derived C1 inhibitor (C1-INH) as first-line treatment in pregnant women with hereditary angioedema (HAE). We conducted a systematic review of the literature that describes experience with plasma-derived C1-INH du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54d0c475062db1a4dc3623328b9f8f0c
https://pubmed.ncbi.nlm.nih.gov/32251736
https://pubmed.ncbi.nlm.nih.gov/32251736
Autor:
Joel P Brooks, Veronica Azmy, Stephanie Prozora, Christina Price, Alison Thompson, F. Ida Hsu, Darren Luon
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 26(1)
Background Hypersensitivity reactions to etoposide have been reported and patients have been safely transitioned to etoposide phosphate for continued therapy. However, the safety and efficacy of substituting etoposide phosphate for etoposide has not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d129d8b6a256cdd7ddcef3693834212
https://pubmed.ncbi.nlm.nih.gov/30885040
https://pubmed.ncbi.nlm.nih.gov/30885040